EPCAM and hepatocellular carcinoma: Figure 8c,d shows the distributions of EpCAM and GPC‐3 mRNA and protein levels, which were calibrated with the ASGPR protein, among early‐stage HCC patients, mid‐to‐late‐stage HCC patients, and healthy donors.